The only significant difference was observed in the tumor border, where in 92% of the non-metastatic CC inflammatory cells were VEGFR-1 positive whereas only 68% of the cases with distant metastasis had a positive immunoreaction (p = 0.02, Figure 1E). The gene discussed is FLT1; the disease is neoplasm.